Key result
Valve retensioning successfully resolved paravalvular leakage and hemolysis following transcatheter mitral valve implantation.
Why the study?
Transcatheter mitral valve implantation can lead to technical issues including left ventricular outflow tract obstruction, paravalvular leakage, and hemolysis.
Does valve retensioning resolve paravalvular leakage and hemolysis after transcatheter mitral valve implantation?
Case Report (n=1)
Does valve retensioning resolve paravalvular leakage and hemolysis after transcatheter mitral valve implantation?
Valve retensioning can successfully resolve paravalvular leakage and hemolysis following transcatheter mitral valve implantation.
Retensioning may address post-TMVI PVL and hemolysis; hypothesis-generating and leaves open prospective validation.
Transcatheter mitral valve implantation is an emerging technology for the treatment of inoperable or high-risk patients with symptomatic severe mitral regurgitation. Known technical issues are obstruction of the left ventricular outflow tract, paravalvular leakage, and hemolysis. We report a case of valve retensioning successfully resolving paravalvular leakage and hemolysis. (Level of Difficulty: Intermediate.)
No takes yet. Share an insight, caveat, or question.
Reineke et al. (2021) conducted a case report in Symptomatic severe mitral regurgitation with post-implantation hemolysis and paravalvular leakage (n=1). Valve retensioning was evaluated on Resolution of paravalvular leakage and hemolysis. Valve retensioning successfully resolved paravalvular leakage and hemolysis following transcatheter mitral valve implantation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: